Literature DB >> 7236887

The endogenous lectin of human platelets is an alpha-granule component.

T K Gartner, J M Gerrard, J G White, D C Williams.   

Abstract

Platelets from patients with several bleeding disorders (congenital afibrinogenemia, Glanzmann's thrombasthenia, gray platelet syndrome, and Hermansky-Pudlak syndrome) were evaluated for both platelet-bound and platelet-free hemagglutination activities. Thrombin and A23187 activated afibrinogenemic, Hermansky-Pudlak, and thrombasthenic platelets had normal platelet-bound hemagglutination activity. Gray platelets activated by the same agents had deficient platelet-bound hemagglutination activity. In contrast, thrombin-activated afibrinogenemic, gray, and thrombasthenic platelets lacked platelet-free hemagglutination activity. Only thrombin-activated Hermansky-Pudlak platelets had a normal level of platelet-free hemagglutination activity. On the basis of these results and the distinguishing characteristics of the defective platelets, it is concluded that the alpha-granules are the origin of the enhanced hemagglutination activity. Furthermore, it is suggested that the insufficiency of the platelet-bound agglutinin may be the cause of the inability of gray platelets to aggregate normally in response to thrombin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236887

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Inhibition of calpain blocks platelet secretion, aggregation, and spreading.

Authors:  K Croce; R Flaumenhaft; M Rivers; B Furie; B C Furie; I M Herman; D A Potter
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

Review 2.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

3.  Thrombospondin fragmentation by alpha-thrombin and resistance to gamma-thrombin.

Authors:  K Takahashi; M Aiken; J W Fenton; D A Walz
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

4.  Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

Authors:  E A Jaffe; J T Ruggiero; L K Leung; M J Doyle; P J McKeown-Longo; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  Complex formation of platelet thrombospondin with histidine-rich glycoprotein.

Authors:  L L Leung; R L Nachman; P C Harpel
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

6.  A monoclonal antibody against human thrombospondin inhibits platelet aggregation.

Authors:  V M Dixit; D M Haverstick; K M O'Rourke; S W Hennessy; G A Grant; S A Santoro; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.

Authors:  B Catimel; L Leung; H el Ghissasi; N Mercier; J McGregor
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

8.  An altered platelet granule glycoprotein in patients with essential thrombocythemia.

Authors:  W J Booth; M C Berndt; P A Castaldi
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

9.  Isolation and characterization of three Ca2+-dependent beta-galactoside-specific lectins from snake venoms.

Authors:  T K Gartner; M L Ogilvie
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

10.  Platelet thrombospondin mediates attachment and spreading of human melanoma cells.

Authors:  D D Roberts; J A Sherwood; V Ginsburg
Journal:  J Cell Biol       Date:  1987-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.